ResultsIQ

ResultsIQ › Latest results › Capillary Technologies India Limited

Capillary Technologies India Limited Q3 FY26 earnings call summary

NSE: CAPILLARY · BSE: 544614

Earnings call of 6 Feb 2026, summarised by AI from the filing.

No specific guidance given; management expects non-COGS cost to grow at inflation plus a few points.

Key takeaways

  1. Guidance No specific guidance given; management expects non-COGS cost to grow at inflation plus a few points.
  2. Change D&A increased to ₹19 cr from ₹13 cr due to Kognitiv acquisition, impacting PAT.
  3. Risk AI disruption in system of engagement and intelligence could impact software firms.

Original filing on BSE

Capillary Technologies India Limited Q1 FY27 results

As filed: Revenue ₹257 cr, EBITDA ₹40.3 cr, PAT −₹9.6 cr, EBITDA margin 15.7%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹257 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹191 cr, EBITDA ₹31.4 cr, PAT ₹43.4 cr, EBITDA margin 16.4%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹191 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −11.8% in 30 days (Nifty 500: −0.5%).
  • Q3 FY26: Revenue ₹184 cr, EBITDA ₹25.0 cr, PAT ₹8.0 cr, EBITDA margin 13.6%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹184 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −14.7% in 28 days (Nifty 500: −4.0%).

Past price moves after results do not indicate future moves. Not a recommendation.

Capillary Technologies India Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.